Covid vaccine: DCGI big announcement on Oxford's Covishield and Bharat Biotech's Covaxin expected at 11 am

The Drug Controller General of India (DCGI) will address a press conference today (January 3) at 11 am and it is being expected that the drug controller watchdog may announce the approval of emergency use of two vaccines. This comes after an expert panel of the drug regulator gave its recommendation on Saturday for the emergency use authorisation of Oxford AstraZeneca's Covishield and Bharat Biotech's Covaxin COVID-19 vaccines. On January 1, Covishield was recommended for emergency use while COVAXIN was recommended for restricted use on January 2. Now a final approval on the use of both the vaccines awaits DCGI nod.

from IndiaTV India: Google News Feed https://ift.tt/38V6mKz
via

COVID-19 vaccination drive based on election process planned to booth level: Harsh Vardhan

COVID-19 vaccination drive based on election process planned down to the booth level and 96,000 vaccinators have been trained so far, said Union Health Minister Dr Harsh Vardhan.

from IndiaTV India: Google News Feed https://ift.tt/38PTzck
via

Delhi: Total 40 UK returnees found positive for COVID so far

A total of 40 people who recently arrived in Delhi from the UK have tested positive for COVID-19, the Health Department of the city government said on Saturday (January 2).

from IndiaTV India: Google News Feed https://ift.tt/3o8d1Yk
via

Air India opens bookings for India-UK flights | Check schedule, routes, booking rules

India’s national carrier Air India has opened booking for flights between India and the United Kingdom. In a tweet, the airline confirmed that the new flights are in addition to the regular flights and tickets could be booked through Air India's website, booking offices, call centre and authorised travel agents.

from IndiaTV India: Google News Feed https://ift.tt/3hEiBiD
via

AIDAN asks DCGI to withdraw approval for Bharat Biotech's Covaxin

The All India Drug Action Network (AIDAN) has urged the DCGI to reconsider the recommendations of the SEC in granting the REU approval to COVAXIN. The AIDAN has said it is shocked to learn about the recommendation to grant REU approval to Bharat Biotech's COVAXIN in "clinical trial mode" and "specially in the context of infection by mutant strains".

from IndiaTV India: Google News Feed https://ift.tt/3o8d5Y4
via

TMC cheated 'Ma, Mati, Manush' in Bengal, says Shekhawat during door-to-door campaign ahead of Bengal polls

Union minister Gajendra Singh Shekhawat on Saturday said that the 'Ma, Mati and Manush' (mother, motherland and people) of West Bengal have been "cheated" during the Trinamool Congress rule in the state.

from IndiaTV India: Google News Feed https://ift.tt/2X2okoL
via

PM Modi rated most popular head of govt by American research firm: Nadda

Prime Minister Narendra Modi has been rated as the most popular head of Government by an American research firm, said BJP President Jagat Prakash Nadda on Saturday.

from IndiaTV India: Google News Feed https://ift.tt/384KoFG
via